CardioGraft-MC® Decellularized Pulmonary Patch

Download the files in the language of your choice
Instructions for Use
Product Specifications


CardioGraft-MC Decellularized Pulmonary Patch is used for right ventricular outflow tract repair and reconstruction.
  • Human Tissue: Closely resembles autograft; compliant, flexible, easy to handle and suture.
  • Resistant to Infection: Natural ability to resist infection.1-3
  • Convenient: Availability in various sizes to best fit the patient’s anatomy.
  • Decellularized: Patented Matracell® technology removes ≥99% of donor DNA.3
  • Clinically Effective: Lower potential for reoperation or intervention. Proven resistance to calcification and stenosis.1,2
  • Efficient: Potentially reduces operating room time and cost by reducing the rate of serious adverse events and reoperations.4
Clinical Application

Repair of the right ventricular outflow tract for:

  • Tetralogy of Fallot
  • Truncus Arteriosis
  • Transposition of the Great Arteries
  • Pulmonary Stenosis/Atresia
Frozen Description Sizing
DPPGK Trunk W = 25 - 50 mm in 5 mm increments; L = 30 - 80 mm in 5 mm increments
DPPGN Branch W = 25 - 50 mm in 5 mm increments; L = 30 - 80 mm in 5 mm increments
  1. Lofland GK, et al. Initial pediatric cardiac experience with decellularized allograft patches. Ann of Thoracic Surg, 2012;93:968-71.
  2. Hopkins RA, et al. Pulmonary Arterioplasty With Decellularized Allogeneic Patches. Ann of Thoracic Surg, Vol. 97, Issue 4, April 2014, Pages 1407-1412.
  3. LifeNet Health data on file: PQ-07-078.
  4. CardioGraft-MC (also known as Matracell®) Decellularized Cardiac Patch Allograft Cost-Effectiveness Analysis Musculoskeletal Clinical Regulatory Advisors, June 2014.